Continuous Blood Glucose Monitoring Global Market Report 2025

Description

Continuous Blood Glucose Monitoring (CGM) involves using a sensor under the skin to constantly track glucose levels. It provides real-time data and alerts for high or low glucose, assisting people with diabetes in managing their blood sugar levels more effectively.

The main components in continuous blood glucose monitoring devices include insulin pumps, sensors, transmitters, and receivers. Insulin pumps are compact, computerized devices that are programmed to administer pre-determined doses of insulin at specific intervals. These devices are particularly utilized by individuals with type 1 diabetes, type 2 diabetes, gestational diabetes, and critical care patients. The end-users for continuous blood glucose monitoring devices include hospitals, homecare diagnostics, and various other settings.

The continuous blood glucose monitoring market research report is one of a series of new reports from The Business Research Company that provides continuous blood glucose monitoring market statistics, including continuous blood glucose monitoring industry global market size, regional shares, competitors with a continuous blood glucose monitoring market share, detailed continuous blood glucose monitoring market segments, market trends and opportunities, and any further data you may need to thrive in the continuous blood glucose monitoring industry. This continuous blood glucose monitoring market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The continuous blood glucose monitoring market size has grown strongly in recent years. It will grow from $13.57 billion in 2024 to $14.87 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increase in diabetes prevalence, regulatory compliance, demand for remote monitoring, emerging markets, rise in healthcare spending.

The continuous blood glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $23.15 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to growing aging population, rising home healthcare, telehealth expansion, rise in healthcare expenditure, rise in disposable income. Major trends in the forecast period include wearable integration, artificial intelligence and machine learning, advanced sensors and accuracy, partnerships and collaboration.

The rising prevalence of diabetes is expected to drive the growth of the continuous blood glucose monitoring market in the future. Diabetes is a health condition characterized by fluctuating blood glucose levels in the body. Blood glucose monitoring devices help identify trends and patterns that provide a clearer overall picture of a diabetic individual's condition. For example, the International Diabetes Federation (IDF) recently reported that approximately 537 million adults aged 20 to 79 are currently living with diabetes worldwide. This figure represents a significant increase from earlier estimates and underscores a troubling trend in diabetes prevalence. The IDF anticipates that this number will reach 643 million by 2030 and further rise to 783 million by 2045. Therefore, the increasing prevalence of diabetes is propelling the growth of the continuous blood glucose monitoring market in the coming years.

The proliferation of hospitals is poised to contribute to the expansion of the continuous blood glucose monitoring market. Hospitals, dedicated to providing medical or surgical treatment, find continuous blood glucose monitoring crucial for precise and ongoing monitoring of blood glucose levels, particularly for patients with diabetes or those at risk of glucose-related complications. According to Discovery Therapy in September 2023, the US had around 6,090 hospitals in 2021, while globally, there were approximately 165,000 hospitals. Additionally, the American Hospital Association reported in May 2023 that there were 6,129 hospitals in America in 2022. The increased number of hospitals globally is expected to drive the growth of the continuous blood glucose monitoring market.

Technological advancements have become a significant trend gaining traction in the continuous blood glucose monitoring market. Major companies in this sector are concentrating on developing cutting-edge technological solutions to strengthen their market position. For example, in 2022, Philips broadened its range of home care solutions for patients with chronic obstructive pulmonary disease (COPD) by launching the BiPAP A40 EFL, a non-invasive ventilator designed to improve patient comfort and decrease hospital readmissions. This ventilator utilizes Philips' proprietary ExpiraFlow technology, which enables healthcare professionals to automatically detect expiratory flow limitation (EFL) in COPD patients and deliver personalized therapy.

Major companies in the diabetes care devices market are innovating new products, such as the Medtronic Extended Infusion Set, to enhance their profitability. The Medtronic Extended Infusion Set is a tubing system designed to deliver insulin from the pump to the body, with a wear duration of up to 7 days. For instance, in 2023, Medtronic Plc expanded the availability of its Extended Infusion Set, which was initially launched in select European countries, to include additional markets throughout Europe and the Asia-Pacific region. This innovative device continues to simplify the insulin delivery process for diabetes patients, featuring a user-friendly all-in-one serter that makes set changes more efficient. The Extended Infusion Set allows for extended wear of up to 7 days, thanks to its advanced technology and materials, significantly exceeding the standard wear duration of typical infusion sets.

In a strategic move in May 2023, Medtronic PLC., an Ireland-based medical device company, acquired EOFlow for an undisclosed amount. This acquisition is geared towards strengthening Medtronic's diabetes product portfolio and expanding its capacity to offer comprehensive support to a larger global community managing diabetes, all within a unified Medtronic ecosystem. EOFlow Co. Ltd., based in South Korea, is recognized for manufacturing the insulin patch pump EOPatch. This strategic acquisition aligns with Medtronic's commitment to continuous growth and innovation in the diabetes care devices market.

Major companies operating in the continous blood glucose monitoring market include F. Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Goldsite Diagnostics Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini Diagnostics, Echo Therapeutics Inc., Johnson & Johnson Services Inc., Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies Inc., Texas Instruments Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality, Nemotecnia S.A.

North America was the largest region in the continuous blood glucose monitoring market in 2023. The regions covered in the continuous blood glucose monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the continuous blood glucose monitoring market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The continuous blood glucose monitoring market consists of sales of real-time continuous glucose monitoring, and intermittently scanned continuous glucose monitoring. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Continuous Blood Glucose Monitoring Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on continuous blood glucose monitoring market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for continuous blood glucose monitoring ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The continuous blood glucose monitoring market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Component: Insulin Pumps; Sensors; Transmitters; Receivers
2) By Application: Type 1 Diabetic Patients; Type 2 Diabetic Patients; Gestational Diabetes; Critical Care Patients
3) By End User: Hospitals; Homecare Diagnostics; Other End Users
Subsegments:
1) By Insulin Pumps: Tubeless Insulin Pumps; Tubed Insulin Pumps; Patch Pumps
2) By Sensors: Continuous Glucose Monitoring Sensors; Flash Glucose Monitoring Sensors; Implantable Sensors
3) By Transmitters: Integrated Transmitters; Wireless Transmitters; Bluetooth-enabled Transmitters
4) By Receivers: Standalone Receivers; Smartphone Apps; Integrated Devices
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Lifescan Inc.; Medtronic plc.; Abbott Laboratories; GlySens Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r32990

1. Executive Summary

2. Continuous Blood Glucose Monitoring Market Characteristics

3. Continuous Blood Glucose Monitoring Market Trends And Strategies

4. Continuous Blood Glucose Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Continuous Blood Glucose Monitoring Growth Analysis And Strategic Analysis Framework

5.1. Global Continuous Blood Glucose Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Continuous Blood Glucose Monitoring Market Growth Rate Analysis
5.4. Global Continuous Blood Glucose Monitoring Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Continuous Blood Glucose Monitoring Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Continuous Blood Glucose Monitoring Total Addressable Market (TAM)

6. Continuous Blood Glucose Monitoring Market Segmentation

6.1. Global Continuous Blood Glucose Monitoring Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Insulin Pumps
Sensors
Transmitters
Receivers
6.2. Global Continuous Blood Glucose Monitoring Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Type 1 Diabetic Patients
Type 2 Diabetic Patients
Gestational Diabetes
Critical Care Patients
6.3. Global Continuous Blood Glucose Monitoring Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare Diagnostics
Other End Users
6.4. Global Continuous Blood Glucose Monitoring Market, Sub-Segmentation Of Insulin Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tubeless Insulin Pumps
Tubed Insulin Pumps
Patch Pumps
6.5. Global Continuous Blood Glucose Monitoring Market, Sub-Segmentation Of Sensors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Continuous Glucose Monitoring Sensors
Flash Glucose Monitoring Sensors
Implantable Sensors
6.6. Global Continuous Blood Glucose Monitoring Market, Sub-Segmentation Of Transmitters, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Integrated Transmitters
Wireless Transmitters
Bluetooth-enabled Transmitters
6.7. Global Continuous Blood Glucose Monitoring Market, Sub-Segmentation Of Receivers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standalone Receivers
Smartphone Apps
Integrated Devices

7. Continuous Blood Glucose Monitoring Market Regional And Country Analysis

7.1. Global Continuous Blood Glucose Monitoring Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Continuous Blood Glucose Monitoring Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Continuous Blood Glucose Monitoring Market

8.1. Asia-Pacific Continuous Blood Glucose Monitoring Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Continuous Blood Glucose Monitoring Market

9.1. China Continuous Blood Glucose Monitoring Market Overview
9.2. China Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Continuous Blood Glucose Monitoring Market

10.1. India Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Continuous Blood Glucose Monitoring Market

11.1. Japan Continuous Blood Glucose Monitoring Market Overview
11.2. Japan Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Continuous Blood Glucose Monitoring Market

12.1. Australia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Continuous Blood Glucose Monitoring Market

13.1. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Continuous Blood Glucose Monitoring Market

14.1. South Korea Continuous Blood Glucose Monitoring Market Overview
14.2. South Korea Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Continuous Blood Glucose Monitoring Market

15.1. Western Europe Continuous Blood Glucose Monitoring Market Overview
15.2. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Continuous Blood Glucose Monitoring Market

16.1. UK Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Continuous Blood Glucose Monitoring Market

17.1. Germany Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Continuous Blood Glucose Monitoring Market

18.1. France Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Continuous Blood Glucose Monitoring Market

19.1. Italy Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Continuous Blood Glucose Monitoring Market

20.1. Spain Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Continuous Blood Glucose Monitoring Market

21.1. Eastern Europe Continuous Blood Glucose Monitoring Market Overview
21.2. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Continuous Blood Glucose Monitoring Market

22.1. Russia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Continuous Blood Glucose Monitoring Market

23.1. North America Continuous Blood Glucose Monitoring Market Overview
23.2. North America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Continuous Blood Glucose Monitoring Market

24.1. USA Continuous Blood Glucose Monitoring Market Overview
24.2. USA Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Continuous Blood Glucose Monitoring Market

25.1. Canada Continuous Blood Glucose Monitoring Market Overview
25.2. Canada Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Continuous Blood Glucose Monitoring Market

26.1. South America Continuous Blood Glucose Monitoring Market Overview
26.2. South America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Continuous Blood Glucose Monitoring Market

27.1. Brazil Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Continuous Blood Glucose Monitoring Market

28.1. Middle East Continuous Blood Glucose Monitoring Market Overview
28.2. Middle East Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Continuous Blood Glucose Monitoring Market

29.1. Africa Continuous Blood Glucose Monitoring Market Overview
29.2. Africa Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Continuous Blood Glucose Monitoring Market, Segmentation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Continuous Blood Glucose Monitoring Market Competitive Landscape And Company Profiles

30.1. Continuous Blood Glucose Monitoring Market Competitive Landscape
30.2. Continuous Blood Glucose Monitoring Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Lifescan Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Medtronic plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlySens Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Continuous Blood Glucose Monitoring Market Other Major And Innovative Companies

31.1. Arkray
31.2. Senseonics Holdings Inc.
31.3. Glysure Limited
31.4. Nemaura Medical Inc.
31.5. Tandem Diabetes Care Inc.
31.6. AgaMatrix Inc.
31.7. B. Braun Melsungen AG
31.8. Ypsomed Holding AG
31.9. Terumo Corporation
31.10. Orsense Ltd.
31.11. Dexcom Inc.
31.12. A. Menarini Diagnostics
31.13. Johnson & Johnson Services Inc.
31.14. Ascensia Diabetes Care Holdings AG
31.15. Insulet Corporation

32. Global Continuous Blood Glucose Monitoring Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Continuous Blood Glucose Monitoring Market

34. Recent Developments In The Continuous Blood Glucose Monitoring Market

35. Continuous Blood Glucose Monitoring Market High Potential Countries, Segments and Strategies

35.1 Continuous Blood Glucose Monitoring Market In 2029 - Countries Offering Most New Opportunities
35.2 Continuous Blood Glucose Monitoring Market In 2029 - Segments Offering Most New Opportunities
35.3 Continuous Blood Glucose Monitoring Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer